Alnylam Pharmaceuticals, Inc. (ALNY) vs Insmed, Inc. (INSM)

Alnylam Pharmaceuticals, Inc. and Insmed, Inc. are both Biotechnology companies. Alnylam Pharmaceuticals, Inc. is the larger, with a market value of $31.2B against $26.8B — 1.2× the size. Insmed, Inc. has negative trailing earnings, so its P/E is not meaningful; Alnylam Pharmaceuticals, Inc. trades at 43.6×. Insmed, Inc. grew revenue faster over the last twelve months: 185.8% against 95.1%. Alnylam Pharmaceuticals, Inc. has the higher net margin (16.1% vs −76.9%) and the higher return on invested capital (0.00% vs −329.2%). Across the 18 metrics below, Alnylam Pharmaceuticals, Inc. leads on 14 and Insmed, Inc. on 4.